These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 18951462)
1. Mechanisms of pathogenicity in human MSH2 missense mutants. Ollila S; Dermadi Bebek D; Jiricny J; Nyström M Hum Mutat; 2008 Nov; 29(11):1355-63. PubMed ID: 18951462 [TBL] [Abstract][Full Text] [Related]
2. Functional analysis of HNPCC-related missense mutations in MSH2. Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302 [TBL] [Abstract][Full Text] [Related]
3. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic? Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549 [TBL] [Abstract][Full Text] [Related]
4. MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system. Belvederesi L; Bianchi F; Galizia E; Loretelli C; Bracci R; Catalani R; Amati M; Cellerino R Hum Mutat; 2008 Nov; 29(11):E296-309. PubMed ID: 18781619 [TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein. Ollila S; Sarantaus L; Kariola R; Chan P; Hampel H; Holinski-Feder E; Macrae F; Kohonen-Corish M; Gerdes AM; Peltomäki P; Mangold E; de la Chapelle A; Greenblatt M; Nyström M Gastroenterology; 2006 Nov; 131(5):1408-17. PubMed ID: 17101317 [TBL] [Abstract][Full Text] [Related]
6. A database to support the interpretation of human mismatch repair gene variants. Ou J; Niessen RC; Vonk J; Westers H; Hofstra RM; Sijmons RH Hum Mutat; 2008 Nov; 29(11):1337-41. PubMed ID: 18951442 [TBL] [Abstract][Full Text] [Related]
7. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer. Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877 [TBL] [Abstract][Full Text] [Related]
8. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC. Ollila S; Fitzpatrick R; Sarantaus L; Kariola R; Ambus I; Velsher L; Hsieh E; Andersen MK; Raevaara TE; Gerdes AM; Mangold E; Peltomäki P; Lynch HT; Nyström M Int J Oncol; 2006 Jan; 28(1):149-53. PubMed ID: 16327991 [TBL] [Abstract][Full Text] [Related]
9. Uncertain pathogenicity of MSH2 variants N127S and G322D challenges their classification. Ollila S; Dermadi Bebek D; Greenblatt M; Nyström M Int J Cancer; 2008 Aug; 123(3):720-4. PubMed ID: 18470917 [TBL] [Abstract][Full Text] [Related]
10. Classification of mismatch repair gene missense variants with PON-MMR. Ali H; Olatubosun A; Vihinen M Hum Mutat; 2012 Apr; 33(4):642-50. PubMed ID: 22290698 [TBL] [Abstract][Full Text] [Related]
11. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair. Wielders EA; Hettinger J; Dekker R; Kets CM; Ligtenberg MJ; Mensenkamp AR; van den Ouweland AM; Prins J; Wagner A; Dinjens WN; Dubbink HJ; van Hest LP; Menko F; Hogervorst F; Verhoef S; te Riele H J Med Genet; 2014 Apr; 51(4):245-53. PubMed ID: 24501230 [TBL] [Abstract][Full Text] [Related]
12. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR]. Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131 [TBL] [Abstract][Full Text] [Related]
13. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076 [TBL] [Abstract][Full Text] [Related]
14. Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae. Gammie AE; Erdeniz N; Beaver J; Devlin B; Nanji A; Rose MD Genetics; 2007 Oct; 177(2):707-21. PubMed ID: 17720936 [TBL] [Abstract][Full Text] [Related]
15. A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants. Drost M; Zonneveld JB; van Hees S; Rasmussen LJ; Hofstra RM; de Wind N Hum Mutat; 2012 Mar; 33(3):488-94. PubMed ID: 22102614 [TBL] [Abstract][Full Text] [Related]
16. New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife. Medina-Arana V; Barrios Y; Fernández-Peralta A; Herrera M; Chinea N; Lorenzo N; Jiménez A; Martín-López JV; González-Hermoso F; Salido E; González-Aguilera JJ Cancer Lett; 2006 Dec; 244(2):268-73. PubMed ID: 16500024 [TBL] [Abstract][Full Text] [Related]
17. Pathogenicity of A600V variant in exon 12 of the MSH2 gene detected in a Japanese kindred with Lynch syndrome. Miyakura Y; Sugano K; Nomizu T; Lefor A; Yasuda Y Jpn J Clin Oncol; 2012 Jan; 42(1):78-82. PubMed ID: 22086974 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the mismatch repair defect in the human lymphoblastoid MT1 cells. Szadkowski M; Iaccarino I; Heinimann K; Marra G; Jiricny J Cancer Res; 2005 Jun; 65(11):4525-9. PubMed ID: 15930269 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry of DNA mismatch repair enzyme MSH2 is not correlated with prognostic data from endometrial carcinomas. Schröer A; Köster F; Fischer D; Dubitscher RM; Woll-Hermann A; Diedrich K; Friedrich M; Salehin D Anticancer Res; 2009 Nov; 29(11):4833-7. PubMed ID: 20032443 [TBL] [Abstract][Full Text] [Related]
20. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells. Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]